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latter tended to distribute independently in a linear pattern,Progressive renal fibrosis in murine polycystic kidney disease:
reminiscent of vasculature adjacent to forming cysts. VIM1An immunohistochemical observation.
expression was not observed in a-SMA1 cells.Background. The appearance of interstitial fibrosis in poly-
Conclusions. Many nonoverlapping as well as fewer overlap-cystic kidneys is emblematic of progressive disease. Matrix form-
ping populations of FSP11 and a-SMA1 cells shared in theing this scar tissue is derived from local renal cells in response
collagen expression associated with progressive fibrogenesis into cystogenesis. We investigated the phenotype of collagen-
pcy mice undergoing cystogenesis. Some FSP11 fibroblasts areproducing cells in the cystic kidneys of DBA/2-pcy mice to
likely derived from tubular epithelium undergoing EMT, whilebetter characterize the spectrum of interstitial cells associated
aSMA1, VIM2 cells probably represent vascular smooth mus-with renal fibrogenesis.
cle cells or pericytes surviving vessel attenuation during theMethods. The extent of interstitial fibrosis and the number
chaos of fibrogenesis. Importantly, not all interstitial cells pro-of fibroblasts in cystic kidneys were first quantitated over time
ducing collagens are a-SMA1.using computer-assisted image analysis. Subsequently, antisera
to four cell protein markers were studied by coexpression im-
munohistochemistry during progression of fibrosis using confo-
cal microscopy. The antisera included fibroblast-specific pro-
Human polycystic kidney disease is a genetic disordertein 1 (FSP1) for fibroblast phenotype, a-smooth muscle actin
that typically expresses as autosomal dominant polycys-(a-SMA) for contractile phenotype, vimentin (VIM) for mes-
enchymal phenotype, and heat shock protein 47 (HSP47) for tic kidney disease (ADPKD) in adults [1–3] and as au-
interstitial collagen-producing phenotype. tosomal recessive polycystic kidney disease (ARPKD)
Results. Interstitial fibrosis in cystic kidneys gradually in- in children [4, 5]. Progression to renal failure is variable
creased throughout the 30-week observation period of our study.
in both disorders [1, 5]. Cysts in the kidney typicallyWith progression of cystogenesis, most of the tubules in pcy
begin as small out-pouchings from any tubular segmentmice either dilated or disappeared with time. FSP11 fibroblasts
were distributed sparsely throughout the renal interstitium of and gradually increase in number and size over time
young pcy and wild-type mice. Their number increased in the [6, 7]. ADPKD is genetically heterogeneous with at least
widening fibrotic septa by 18 weeks of age and persisted through three genes involved: PKD1, which accounts for approxi-
30 weeks of the study interval. Some epithelia among remnant
mately 85 to 95% of all ADPKD and maps to chromo-tubules trapped within fibrotic septa around adjacent cysts also
some 16p13.3 [2, 3]; PKD2, located on chromosome 4,acquired the phenotype of FSP11, HSP471 collagen-producing
fibroblasts, suggesting a possible role for epithelial-mesenchy- which accounts for most of the remaining cases [8, 9];
mal transformation (EMT) in this process. Most FSP11 fibro- and the hypothesized PKD3, which is not yet mapped
blasts were a-SMA2, but HSP471, suggesting they were pro- [10]. The PKHD1 gene responsible for ARPKD alsoducing collagen proteins for the extracellular matrix. a-SMA1,
remains elusive on chromosome 6 [11].FSP12, HSP471 or HSP472 cells were also observed, and the
There are a number of animal models representing
polycystic kidney disease [12, 13]. In addition to several
Editor’s Note: Jared Grantham served as Guest Editor during the models of hereditary cystogenesis, null alleles of murine
review of this article. PKD1 and PKD2 have also been used to create mouse
homologues of human cyst formation [14–16]. Such nullKey words: fibroblast, myofibroblast, a-smooth muscle actin, heat
shock protein 47. mice, especially when homozygous, develop severe cystic
disease with many dying in utero or during early adult-Received for publication August 12, 1999
hood [14–16]. Among recessive models of spontaneousand in revised form January 27, 2000
Accepted for publication February 18, 2000 cystogenesis, the DBA/2-pcy mouse (pcy mouse) exhib-
its a slowly progressive form of disease with a phenotypeÓ 2000 by the International Society of Nephrology
587
Okada et al: Renal fibrosis in polycystic kidney disease588
reminiscent of human polycystic kidneys [12, 17]. Al- Fujita Health University (Toyoake, Japan). At weeks 4,
though the pcy gene localizes to chromosome 9 and is 8, 18, and 30, four pcy mice were sacrificed at each interval,
not murine PKD1 and PKD2, the pcy phenotype has and kidneys were harvested from each mouse at sacrifice.
been useful in exploring the potential pathophysiology
Histologic, immunohistochemical, andof human cystogenesis [12, 17, 18].
immunofluorescence examinationThe initial morphologic changes seen in the kidneys
of newborn pcy mice consist of segmental dilations along A part of each kidney was fixed in 4% paraformalde-
distal tubules and collecting ducts and, by four weeks of hyde and was embedded in paraffin. Another part of it
age, include the beginning of random cysts along proxi- was directly snap frozen for immunofluorescent exami-
mal tubules and ascending limbs [18]. While the cysto- nation. Sections were cut 4 mm in thickness from paraffin
genesis itself is thought to be a primary driver of organ blocks and processed for hematoxylin-eosin (HE), Mas-
injury [12, 17], several laboratories have also stressed son’s trichrome (MT), and periodic acid-methenamine-
the important relationship between the appearance of silver (PAM), and indirect immunoperoxidase staining.
interstitial fibrosis and the progression of disease [19–22]. For the latter, after deparaffinization and rehydration,
Progression to end-stage cystic disease is associated with the sections were treated with proteinase K and boiled
the accumulation of interstitial collagens and an increase in citrate buffer under microwave for unmasking anti-
in cellularity, presumably because of proliferation of fi- genicities [31], and then they were immersed in 3% H2O2
broblasts [23]. The expression of genes encoding extracel- in methanol for inhibition of endogenous peroxidase and
lular matrix in pcy kidneys includes increased amounts flooded with 5% bovine albumin in PBS for inhibition of
over time of mRNA encoding fibronectin and a1(III) nonspecific reactions. Rabbit anti-FSP1 (1:500) [26] and
procollagen [24], although the phenotypes of the cells mouse anti–a-SMA (1:500; Sigma, St. Louis, MO, USA)
expressing these moieties are not yet known. were applied as primary antibodies. Following primary
The cell(s) driving interstitial collagen formation in immunoreaction, labelling was performed using relevant
renal fibrosis has not been easy to characterize, although biotin-conjugated, secondary antibodies and a Vectastain
a tissue fibroblast seems a likely candidate [20]. Identifi- ABC kit (Vector Laboratories, Burlingame, CA, USA),
cation of interstitial cells producing collagens in vivo has and was visualized using diaminobenzidine (DAB) as a
been particularly hampered by low copy numbers of substrate.
mRNA encoding interstitial collagens and low levels of Indirect immunofluorescence was performed on 4 mm
secreted proteins. Fortunately, a number of new pheno- in thickness, 4% paraformaldehyde-fixed cryostat sec-
typic markers have appeared in recent literature. The tions with rat anti–E-cadherin (1:100; Sigma) and rat anti-
observation that the more abundant heat shock protein
cytokeratins (TROMA-1 and 3, 1:500 [32]) as primary47 (HSP47) is coexpressed as an intracellular chaperon
antibodies with FITC-conjugated anti-rat IgG (1:500;during the synthesis of interstitial collagens has made
American Qualex, San Clemente, CA, USA) as second-the identification of collagen-producing cells more prac-
ary antibodies [27]. These sections were observed withtical in tissues [25]. We have also cloned fibroblast-spe-
a laser microscope (Provis Ax; Olympus, Tokyo, Japan)cific protein 1 (FSP1), a murine fibroblast-specific protein
equipped with appropriate filters. For dual staining, reac-belonging to the S100 superfamily of intracellular cal-
tion with anti-FSP1 was followed by Rhodamine-conju-cium-binding proteins [26]. FSP1 is a cytoplasmic marker
gated antirabbit IgG (1:500; Chemicon Internationalof resting and activated fibroblasts as well as of epithe-
Inc., Temecula, CA, USA), and then reaction with FITC-lium undergoing epithelial-mesenchymal transformation
conjugated anti–a-SMA (1:500; Sigma) was carried out.(EMT) [26, 27]. We wanted to compare the coexpression
HSP47 is a collagen-binding stress protein found inof these new markers with a-smooth muscle actin (a-
cells producing collagens [25]. To characterize furtherSMA), which is normally synthesized by vascular smooth
FSP11 or a-SMA1 cells expressing HSP47, several differ-muscle cells, activated vascular pericytes, or contractile
ent costainings were performed. Mouse anti-HSP47fibroblasts in granulation tissue known as myofibroblasts
(StressGen Biotechnologies, Victoria, Canada) conju-[20, 28, 29], as well as vimentin (VIM), which is expressed
gated with FITC using a FITC Protein Labeling Kit (Boeh-ubiquitously in mesenchymal cells [20, 30]. With this
ringer Mannheim GmbH, Mannheim, Germany) and/orcollection of reagents, we have characterized the pheno-
goat-anti-VIM (VIM; Sigma) were used. The representa-type of collagen-producing cells in polycystic kidneys of
tive sections were stained with anti-FSP1 in combinationpcy mice during their fibrosis.
with Rhodamine-conjugated anti-rabbit IgG or Cy3-con-
jugated anti–a-SMA (1:100, Sigma) as primary antibod-
METHODS ies, and each was then treated with FITC-conjugated
Murine model of ADPKD anti-HSP47 (1:100) or anti-VIM (1:50) followed by FITC-
conjugated anti-goat IgG (1:500; Chemicon). These dual-Male DBA/2-pcy mice were obtained from a breeding
colony maintained in the Laboratory Animal Center, stained sections were analyzed by a confocal microscope
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(MRC600; Bio-Rad, Hercules, CA, USA). All of the
second antibodies had been isolated by immunoaffinity
chromatography and absorbed for dual labeling. Con-
trols included omitting the primary antibody and/or sub-
stituting the primary antibody with normal murine IgG.
Quantitation of collagenous fibrotic area and FSP11
cells in the tubulointerstitium
Interstitial areas of fibrosis and numbers of fibroblasts
were quantitatively evaluated by computer-assisted im-
age analyzer (Mac SCOPE, Version 2.5; Mitani Corp.,
Hukui, Japan). Thirty cortical fields were randomly ana-
lyzed at 3200 magnification from each kidney sample
evaluated. Luminal areas of cysts were subtracted from
each field, and then the collagenous fibrotic area in blue
and FSP11 cells in brown was quantitatively determined;
each was expressed as a mean percentage area or mean
cell count per field.
RESULTS
Renal fibrosis in pcy mice became progressively more
severe over the study interval of 30 weeks. The intensifi-
cation of interstitial fibrosis is demonstrated in Figure 1
using a quantitative index based on area involvement.
Table 1 further collates the longitudinal overview of phe-
notypic markers expressed during fibrosis in these cystic
kidneys over time. At four weeks of age, the tubulointer-
stitium was largely normal with only sporadic dilation
of distal tubular segments and collecting ducts. FSP11
fibroblasts were sparsely distributed in the renal intersti-
tium, especially around dilated tubules (Fig. 2A). Dilated
Fig. 1. Analysis of renal interstitial fibrosis and fibroblasts in pcy mice.tubules and cysts increased in number by eight weeks
The percentage area of collagenous involvement (A) and mean number
of age. Many areas adjacent to these cysts remained of FSP11 cells (B) in the kidneys of pcy mice gradually increased in
amount or number in time-dependent fashion over the 30-week studyrelatively normal with minimal interstitial expansion or
interval. Each point represents the mean 6 SEM for groups of fourloss of vessels and tubules, while other areas had become
pcy mice. *P , 0.05 vs. four-week-old pcy mice.
slightly fibrotic (data not shown). An increasing number
of FSP11 cells were also present in those areas of intersti-
tium changed by fibrosis (Fig. 2B). In these areas, only
vascular smooth muscle cells were a-SMA1 (Fig. 2C).
partially dismantled by septal fibrosis, there were disrup-At this stage, epithelia in most normally sized tubules
tions in tubular basement membrane (Fig. 3E). Renaland most of the epithelia lining dilated tubules were
vessels were also trapped in these fibrotic septa (Fig.positive for cytokeratin (Fig. 2D).
3F), and their remaining cells stained positive for a-SMACystogenesis in pcy mice progressed further by 18
(Fig. 3G). Cytokeratin staining at this stage identifiedweeks of age to where numerous cysts were distributed
most cystic epithelia but not all remnant tubular epitheliarandomly throughout the kidney cortex. They varied in
trapped within expanding segments of scar (Fig. 3H) [33].size, with large ones often insinuated between banded
Since the number of FSP11 interstitial cells was sig-tissues of fibrotic scar (Fig. 3A). Such intersecting areas
nificantly greater in 18-week-old mice, and interstitialof interstitial fibrosis contained smaller cysts, atrophic
fibrosis itself progressed even further between 18 and 30tubules, vessels, residual glomeruli, and cells positive
weeks of age (Fig. 1), we chose to phenotype interstitialfor FSP1 (Fig. 3B). Tubular epithelia in transition areas
cells in 18-week tissue that still possessed familiar ana-adjacent to these fibrotic septa also become FSP11, as
tomic landmarks. Double-stained sections of pcy kidneydid occasional epithelia among involved cysts (Fig. 3C;
Fig. 3D is a negative control). In tubules trapped and revealed that FSP11 fibroblasts and a-SMA1 cells were
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Table 1. Alterations in phenotypic markers in the kidneys of pcy mice
4-week-old 8-week-old 18-week-old 30-week-old
Marker Site mice mice mice mice
FSP1 INT 1a 1a 11 11
TE 2 1b 1b 6c
a-SMA INT 1d 1d 11 11
TE 2 2 2 6c
E-cadherin TE 1 1 6b, 2e 2
Cytokeratin TE 1f 1f 1e, 6f 1e
Abbreviations are: INT, interstitium; TE, tubular epithelium.
aRemarkable around cysts
bEpithelium of some tubules adjacent to expanding cysts
cSegmental epithelium of expanded cysts
dRestricted to cells of the renal vasculature
eEpithelium lining some dilated tubules or expanding cysts
fEpithelium of remnant tubules
typically nonoverlapping (Fig. 4 A, B). Some FSP11 in- cysts spontaneously arise as dilations from any segment
terstitial fibroblasts were also HSP471 (Fig. 4C; yellow/ of the nephron [1, 12, 17], and their number over time
arrows), and also some of the a-SMA1 interstitial cells can rise to several hundred in a murine kidney of 5 to
were HPS471 (Fig. 4D; yellow/arrows). Thus, FSP11, 6 3 105 nephrons.
a-SMA2 fibroblasts and FSP12, a-SMA1 interstitial cells In addition to forming cysts, all species with polycystic
both seemed capable of producing interstitial collagens. kidney disease develop other structural alterations to
Of note, a few epithelial cells in some tubules were dual their interstitium that disturb important functional rela-
positive for FSP1 and HSP47 (Fig. 4C; arrowheads). Some tionships between and among nephrons. Destruction of
FSP11 fibroblasts were also VIM1 (Fig. 4E; yellow/arrows), the tubulointerstitium by fibrogenesis is the most obvi-
but a-SMA1 interstitial cells were VIM2 (Fig. 4F). ous, but the least well studied in detail. In this observa-
By 30 weeks of age, large cysts were abundant, and tional report, we have begun to characterize the cellular
normal tubules were in a minority (Fig. 5A). Resulting components contributing to this fibrogenesis.
fibrous septa contained an abundance of FSP11 intersti- Based on our findings, the origin of collagen-producing
tial fibroblasts (Fig. 5B), while a-SMA1 interstitial cells cells in the interstitium during cystogenesis potentially
tended to distribute linearly around cysts (Fig. 5C). In includes several phenotypes: pre-existing FSP11 fibro-
addition, epithelial cells lining expanded cysts were occa- blasts that multiply in number, FSP11 fibroblasts that
sionally negative for E-cadherin (Fig. 5D; arrowheads), migrate into the interstitium from external sources, FSP11
but all of them were still strongly positive for cytokera- fibroblasts that change their phenotype into a-SMA1
tins (Fig. 5E), suggesting that cystic epithelium share myofibroblasts, a-SMA1 vascular smooth muscle cells
a dynamic and shifting phenotype. Reactivity for each that cut loose in the interstitium, or new FSP11 fibro-
experimental control was mostly negative, and back- blasts that appear following EMT [26, 27].
ground activity was minimal (Fig. 3D). While fibroblasts undoubtedly exist in the bone mar-
row, previous experiments in parabiotic rats suggest that
tissue fibroblasts, when needed, do not accumulate fromDISCUSSION
hematogenous sources [48], as once thought [49]. ManyPolycystic kidney diseases are a group of disorders rec-
FSP11 fibroblasts in the kidneys of four week-old pcyognized by the emergence of numerous cysts throughout
mice are thought to be daughters of native fibroblasts,the nephron mass. Four types of epithelial cell distur-
since FSP11 fibroblasts were especially apparent aroundbances have been implicated in the process of cystogen-
dilating tubules absent other pathological alterations,esis: (1) Renal tubules undergo cystic dilation while chang-
like cell infiltration, tubular atrophy, or widening of theing their polarization [34–38]; (2) epithelia begin to
interstitium (Fig. 1A). This coincidence suggests that theproliferate abnormally [39–41]; (3) apoptosis reduces ep-
proliferation of native fibroblasts in cystic kidneys byithelial cell mass [42–44]; and (4) cystic segments synthe-
fibroblast growth factors like platelet-derived growth fac-size aberrant basement membranes [23, 24, 35, 45–47].
tor, angiotensin II, endothelin, or FGF2 may be stimu-While this process is likely facilitated by the absence of
lated by resident somatic cells from within the samepolycystin in null mice or humans with ADPKD [7],
microenvironment of dilating tubules or cysts [50].the genetics and mechanism of cyst formation in mouse
From 8 to 18 weeks of age, the number of FSP11strains with hereditary cystic disease are still uncertain.
In pcy mice, the model we have studied in this report, fibroblasts in the kidneys of pcy mice continued to in-
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Fig. 2. Renal histopathology of 4- and 8-week-old pcy mice. (A) FSP11 fibroblasts in four-week-old pcy mice distributed sparsely in the interstitium
but increased especially around dilating tubules (arrows; (DAB, 3200). (B) An increasing number of FSP11 cells in eight-week-old pcy mice
reside in the widening interstitium (arrows; DAB, 3200). (C) All of the a-SMA positivity in eight-week-old pcy mice expressed exclusively within
vascular smooth muscle cells (arrows; DAB, 3200). (D) Epithelia in most of normal-sized tubules in eight-week-old pcy mice and almost all the
dilating tubules were positive for cytokeratins (FITC, 3200).
crease with the envelopment of cystogenesis by septal volved tubular segments, or enlarging cysts, continued
to remain positive for cytokeratins. In contrast, residualfibrogenesis. In addition to growth factors, compression
by expanding cysts and the attendant ischemia of adja- tubular epithelium interwoven or trapped by forming
fibrotic septa were increasingly negative for cytokeratin,cent renal parenchyma may accelerate fibroblast pres-
ence as well. The renin-angiotensin system is activated suggesting as a hypothesis that such epithelium stop ex-
pressing cytokeratins as their units are dismantled byin the ADPKD [22, 51], and angiotensin II as a fibroblast
growth factor and morphogenic cytokine can induce re- EMT and engulfed by scar. Epithelia in tubules adjacent
to expanding cysts and septa were also double positivenal fibrosis in rats [52]. Furthermore, angiotensin-con-
verting enzyme inhibitors are efficacious in reducing cyst for FSP1 (Fig. 3C) and HSP47, suggesting they were
producing interstitial collagens (Fig. 4C) at the edge ofsize in rat model of ADPKD [53, 54]. Thus, fibroblasts
by several potential mechanisms can be driven to expand a fibrotic front. Tubular epithelial cells transformed by
local paracrine factors benefit from the disruptions offibrogenesis in cystic kidneys.
The notion that some interstitial fibroblasts may be basement membrane as they go through EMT (Fig. 3E)
[24, 55]. These disruptions are probably accelerated byderived from tubular epithelium is of particular interest
to us. Renal tubular epithelium in distal tubules and metalloproteases released by the epithelium as they be-
gin this transformation (Strutz et al, manuscript in prepa-collecting ducts typically stain positive for cytokeratin
[33], so it was reasonable to expect that such tubules ration). FSP11 fibroblasts can also be VIM1 or VIM2
(Fig. 4E) or HSP471 or HSP472 (Fig. 4C). This variabilitywould be cytokeratin positive in young pcy mice (Fig.
2E). Most of the epithelia comprising seemingly unin- may reflect the degree of engagement by morphogenic
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Fig. 3. Renal histopathology of 18-week-old pcy mice. (A) In HE-stained sections, the cysts varied in size, and widened fibrotic septa between
those cysts contained intact to atrophic tubules, vessel, and infiltrates (arrows; 3200). (B) FSP11 fibroblasts existed in thin to thick walls of cysts
(arrows; DAB 3400). (C ) FSP11 tubular epithelial cells were found within reactive tubules adjacent to expanding cysts (arrows). A few of the
epithelial cells lining cysts showed FSP11 as well (arrowhead; DAB 3400). (D) Negative control for (C) using a serial section (DAB 3400). (E )
In PAM-stained sections, the interstitial areas surrounded by expanding cysts, the basement membrane of residual tubules and cysts were disrupted
(arrows; 3200). (F ) In HE-stained sections, the thin epithelial layer lining a cyst was immediately opposed to a small intrarenal artery (arrows;
3200). (G) a-SMA1 cells in the interstitium were derived from vascular walls (arrowhead at interlobular artery) and tended to form lines encircling
cysts (arrows; DAB 3200). (H ) All epithelial cells lining cysts were positive for cytokeratins, while others among remnant tubules within fibrotic
septa had become negative (arrows; FITC 3200).
cytokines. Such cells in cystic kidney for the most part in cystic kidneys of pcy mice were HSP471 (Fig. 4D),
indicating they were also synthesizing interstitial collagenswere surprisingly a-SMA2 (Fig. 4 A, B).
Only obvious vascular structures were a-SMA1 in [25]. Nevertheless, only occasional a-SMA1 cells were
FSP11 (Fig. 4 A, B). This latter finding suggests thatearly cystic kidneys of pcy mice. These vascular smooth
muscle cells remained a-SMA1 as the kidney became detection of a-SMA1 cells alone may significantly under-
estimate the actual fibroblast population. In preliminarymore cystogenic, and the residual vasculature formed
remnant ghosts suggestive of former vessels (Fig. 3F). experiments, we have also observed that a-SMA1,
FSP12 or a-SMA2, FSP11 cells are more common thanAlternatively, vascular pericytes can become SMA1 in
certain situations [56] and may represent a possible ori- double-positive cells in the interstitial fibrosis associated
with murine Goodpasture syndrome or transgenic HIVgin of new a-SMA1 interstitial cells. Their absence of
VIM positivity noted previously in this article may reflect nephropathy (Okada; unpublished data).
Tubular epithelium in culture undergo EMT whena nonmesenchymal origin.
a-Smooth muscle actin1 cells in fibrotic tissue have grown in type I collagen and pressured by cytokines,
particularly transforming growth factor-b (TGF-b) andalso been referred to as activated fibroblasts or myofi-
broblasts [28, 30]. Some of the a-SMA1 interstitial cells epidermal growth factor (EGF) [27]. The fibroblasts that
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Fig. 3. (Continued)
emerge from this transformation after several days in complex: The heterogeneity of cell fate among partici-
pating cells is far greater than anticipated. Most impor-culture often have a phenotype not unlike what has been
tant, overlapping positivity between FSP1 and a-SMAcalled a myofibroblast: They are FSP11, a-SMA1, VIM1.
markers in the interstitium among collagen-producingWhy this double positivity can be recognized clearly in
cells is far less that originally suspected. a-SMA positivityculture but not in tissue is unclear. We hypothesize that
cannot be construed as a gold standard for all collagen-it may depend on availability or strength of the cytokine
expressing cells during fibrogenesis, and suggests thatenvironment. EGF and TGF-b, for example, can be de-
the further study of the mechanism of this phenotypictected in the kidneys of pcy mice [50, 57], and we can
diversity will be an important facet to understandingdetect type I collagen by immunohistochemistry in their
progressive renal disease.interstitium (data not shown). The transcription of EGF
and TGF-b genes, however, are down- and up-regulated,
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Fig. 4. Dual immunofluorescence on the fibrous interstitium of the kidneys of 18-week-old pcy mice. (A and B) FSP11 cells (in red) and a-SMA1
cells (in green) were clearly different from each other, since there were no cells registered in yellow, indicating an absence of dual positive cells
(FITC and Rhodamine 3400). (C ) Some of the FSP11 cells registered yellow [FSP11 cells (in red) and HSP471 cells (in green)] because of dual
positivity for HSP47 (arrows). The epithelial cells in atrophic tubules (arrowheads) were found to be dual positive for FSP1 and HSP47 (FITC
and Rhodamine 3400). (D) Some of the a-SMA1 cells registered yellow [a-SMA1 cells (in red) and HSP471 cells (in green)] because of dual
positivity for HSP47 (arrows). However, aSMA1 cells distributing linearly around cysts (arrowheads) tended to stain red, indicating they were
HSP472 (FITC and Cy3 3400). (E ) Some of FSP11 cells also registered yellow [FSP11 cells (green) and VIM1 cells (red)], demonstrating dual
positivity for VIM (arrows; FITC and Rhodamine 3400). (F ) There were no dual-positive cells when stained for a-SMA1 cells (green) and VIM1
cells (red; (FITC and Rhodamine 3400).
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Fig. 5. Renal histopathology of 30-week-old pcy mice. (A) In HE-
stained sections, a number of cysts were distributed throughout the
tissue. Cyst walls and fibrotic septa between cysts contained few normal
structures (3200). (B) A number of FSP11 cells existed as solitary
cells in adjacent fibrous cyst walls (DAB 3200). (C ) a-SMA1 cells
distributed in linear pattern along fibrous cyst walls (arrows), and their
pattern of distribution seemed different from FSP11 cells seen in B
(DAB 3200). (D) Epithelial cells among small cysts were still strongly
positive for E-cadherin on their cell surface (arrow), but E-cadherin
expression was often weaker in the epithelium lining an expansive cyst
(arrowheads; FITC 3400). (E ) All of the epithelium lining expansive
cysts were strongly positive for cytokeratins, suggesting a persistent
epithelial phenotype (FITC 3200).
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